From: The effects of progesterones on blood lipids in hormone replacement therapy
Composition | dosage forms | Available dosages |
---|---|---|
Progestogen-only | ||
Progesterone | Soft Capsules | 100, 200Â mg |
vaginal gel | 4%, 8% gel | |
Medroxyprogesterone Acetate | Oral tablet | 2.5, 5, 10, 100, 500Â mg |
Norethisterone (norethindrone)b | Oral tablet | 0.35Â mg |
Levonorgestrel | Implants, Tablets, Intrauterine device | 1.5Â mg, 36Â mg, 52Â mg |
Norgestrel | Tablets | 0.075Â mg, 3Â mg |
Dydrogesteronea | Tablets | 10Â mg |
Combined with estrogen | ||
estradiol + norethindrone acetate | Film, Extended release /Transdermal | 50 μg/24 h; 0.14 mg/24 h; 50 μg/24 h; 0.25 mg/24 h; 10 mg E + 30 mg P |
Tablets/Oral | 1Â mg/0.5Â mg; 0.5Â mg/0.1Â mg | |
estradiol + drospirenone | Tablets/Oral | 0.5Â mg/0.25Â mg; 1Â mg/0.5Â mg; 1Â mg/2Â mg |
estradiol + dydrogesteronea | Tablets/Oral | 1Â mg/10Â mg |
estradiol + cyproterone acetatea | Tablets/Oral | 2Â mg/1Â mg |
conjugated equine estrogens + medroxyprogesterone acetateb | Tablets/Oral | 0.3Â mg/1.5Â mg; 0.45Â mg/1.5Â mg; 0.625Â mg/2.5Â mg; 0.625Â mg/5Â mg |
ethinyl estradiol + norethindrone acetateb | Tablets/Oral | 5 μg/1 mg; 25 μg/0.5 mg |